Streetbeat News

LUCY

Innovative Eyewear, Inc.

https://www.lucyd.co

Industry

Medical - Instruments & Supplies

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear, Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd.

Open

6.80

Mkt cap

16M

Volume

96K

High

7.13

P/E Ratio

-0.63

52-wk high

27.20

Low

6.70

Div yield

N/A

52-wk low

3.26

In Wednesday's pre-market session, health care stocks showed significant movement. Immutep, Syra Health, Sage Therapeutics, Recursion Pharmaceuticals, Viracta Therapeutics, and BioVie were among the gainers, with increases ranging from 11.87% to 15.5%. Conversely, Evotec, Innovative Eyewear, Ovid Therapeutics, BiomX, Kiora Pharmaceuticals, and Addex Therapeutics experienced declines between 13.72% and 32.2%. Notably, Evotec and Addex Therapeutics' stock movements were influenced by their Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 12:06 pm

In Friday's after-market session, several healthcare stocks showed notable movements. Mobile-health Network (MNDR) led the gainers with a 15.0% increase, while Vaxxinity (VAXX) experienced the largest drop among the losers, declining by 10.7%. Other notable movers included Galera Therapeutics (GRTX) and Titan Pharma (TTNP).

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 8:31 pm

Innovative Eyewear, Inc. has announced the signing of UK football legend Micah Richards as an official brand ambassador for its ChatGPT smart eyewear under the Lucyd, Nautica, Eddie Bauer, and Reebok brands. Richards, a former England International footballer and successful broadcaster, is expected to help the company reach new athletes and sports fans, increasing brand awareness.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:44 pm

Innovative Eyewear has entered into a distribution partnership with Windsor Eyes, aiming to expand its market reach and enhance product distribution. This strategic move is expected to positively impact Innovative Eyewear's distribution capabilities and market presence.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:32 pm

Maxim Group analyst Matthew Galinko has maintained a Buy rating on Innovative Eyewear (NASDAQ:LUCY) but has lowered the price target from $1.75 to $1. This adjustment reflects a revised valuation of the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 1:21 pm

Innovative Eyewear (NASDAQ:LUCY) reported Q4 earnings with a loss of $(0.19) per share, missing the $(0.14) estimate, but sales of $615.75K exceeded the $200.00K estimate, marking significant year-over-year growth.

Portfolio Pulse from Happy Mohamed

March 25, 2024 | 8:29 pm

Innovative Eyewear (NASDAQ:LUCY) reported Q4 earnings with an EPS of $-0.19, missing estimates by -36.0%. Revenue increased by $548 thousand from the previous year. Last quarter, the company beat EPS estimates, which led to a 0.0% change in share price the following day.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 1:25 pm

Innovative Eyewear Inc. (NASDAQ: LUCY) reported a 75% increase in FY23 revenue, reaching $1,152,479 from $659,788 YoY. Q4 2023 sales hit a record $615,754, marking the fourth consecutive quarter of growth. Despite this, the net loss widened to $6,663,428 from $5,681,833 due to operational scale-up. The company attributes growth to direct-to-consumer and Amazon sales, and anticipates further growth with the launch of new smart eyewear lines in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:36 pm

In Wednesday's after-market session, several health care stocks showed significant movement. NanoString Technologies, Tenax Therapeutics, and Revelation Biosciences were among the top gainers, while Sana Biotechnology, Sensus Healthcare, and MSP Recovery led the losers. The movements were attributed to various factors, including market reactions to company performances and recent earnings reports.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:31 pm

Innovative Eyewear has commenced the shipping of its Nautica Smart Eyewear Collection, marking a significant step in the company's product distribution.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.